SCHEMBL3404302

SCHEMBL3404302

Brc1ccc2nc(NC3COc4ccccc43)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.37
HTR2A P28223 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
P2RX7 Q99572 1/20 0.35
HTR1A P08908 1/20 0.34
SORT1 Q99523 1/20 0.34
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
CYP2A6 P11509 1/20 0.33
PDE10A Q9Y233 2/20 0.32
MAPK1 P28482 2/20 0.32
MAPT P10636 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
KMT2A Q03164 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 2/20 0.32
XIAP P98170 2/20 0.32
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3409292 0.85 PLAU (0.39) HTR2ADDB1CRBNP2RX7HTR1A
SCHEMBL3413339 0.80 HTR1A (0.40) HTR1AMAPTNPC1RAB9AKMT2A
SCHEMBL3403271 0.80 XIAP (0.35) HTR2AHTR1AXIAP
SCHEMBL4106721 0.78 KDM1A (0.37) MAPK1MAPTKMT2ASMN1; SMN2HTT
SCHEMBL3404459 0.78 FADS1 (0.43) DDB1CRBNLMNAPFKFB3
SCHEMBL4106465 0.78 FADS1 (0.43) DDB1CRBNLMNAPFKFB3
SCHEMBL4100059 0.77 RIPK1 (0.37) P2RX7MAPK1MAPTNPC1RAB9A
SCHEMBL4107588 0.77 KDM1A (0.38) P2RX7MAPK1MAPTNPC1RAB9A
SCHEMBL3415258 0.76 BRD4 (0.42) MAPTSMN1; SMN2HTTHPGD
SCHEMBL3414720 0.74 NPY1R (0.45) MAPK1MAPTNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188284-B2 2-aminoquinolines HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
EP-2252372-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-11-24 EP disclosed
WO-2009109502-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227583-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227583-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2B BACE1 423/4885HTR2A 4/4885DDB1 2424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.